Acarix AB (publ) Stock Nasdaq Stockholm
Equities
SE0009268717
Advanced Medical Equipment & Technology
Sales 2024 * | 86.9M 8.06M 10.99M | Sales 2025 * | 191M 17.74M 24.19M | Capitalization | 242M 22.44M 30.61M |
---|---|---|---|---|---|
Net income 2024 * | -24M -2.23M -3.04M | Net income 2025 * | 58M 5.38M 7.33M | EV / Sales 2024 * | 2.74 x |
Net cash position 2024 * | 4M 371K 506K | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.27 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.07% |
Latest transcript on Acarix AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 06-12-31 | |
Director of Finance/CFO | 60 | 15-12-31 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 21-05-10 | |
Ulf Rosén
BRD | Director/Board Member | 64 | 13-12-31 |
Director/Board Member | 70 | 21-05-10 |
1st Jan change | Capi. | |
---|---|---|
-12.27% | 19.25B | |
-40.05% | 2.96B | |
+23.79% | 1.96B | |
+1.29% | 1.69B | |
+28.42% | 1.27B | |
-14.61% | 982M | |
-20.31% | 913M | |
+4.57% | 801M | |
-24.78% | 630M |